SCHEMBL1992302

SCHEMBL1992302

O=c1oc2ccccc2cc1C[AsH2]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.58
MAOB P27338 5/20 0.56
MMP2 P08253 1/20 0.55
MMP9 P14780 1/20 0.55
ADAM17 P78536 1/20 0.55
HPGD P15428 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
TYR P14679 1/20 0.55
DAO P14920 1/20 0.55
AKR1B1 P15121 1/20 0.55
POLB P06746 1/20 0.55
RAB9A P51151 4/20 0.51
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
CA12 O43570 3/20 0.50
CA9 Q16790 3/20 0.50
CA1 P00915 2/20 0.50
CA3 P07451 1/20 0.50
TSHR P16473 1/20 0.50
CA4 P22748 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13612673 0.85 MAOA (0.61) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL27625488 0.85 MMP2 (0.67) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL1619109 0.83 MAOB (0.67) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL30594160 0.83 MAOB (0.67) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL25306495 0.81 MAOA (0.58) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL765821 0.81 MAOA (0.58) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL294595 0.81 MAOA (0.58) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL29934196 0.81 POLB (0.59) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL3009674 0.81 HPGD (0.59) MAOAMAOBMMP2MMP9ADAM17
SCHEMBL94133 0.81 POLB (0.59) MAOAMAOBMMP2MMP9ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2337784-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2011-06-29 EP disclosed
WO-2010036871-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-04-01 WO disclosed
WO-2006023209-A2 USES OF NOTCH RECEPTORS, NOTCH LIGANDS, AND NOTCH MODULATORS IN METHODS RELATED TO METABOLIC DISEASES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH (US) 2006-03-02 WO disclosed